Fig. 2. Timeline depicting the discovery of factors crucial for GBS vaccine development. CPS, capsular polysaccharide; GBS, Group B Streptococcus; CDC, Centers for Disease Control and Prevention; ACOG, the American College of Obstetricians and Gynecologists; AAP, the American Academy of Pediatrics; WHO, World Health Organization.
Ann Clin Microbiol 2023;26:41-50. Group B Streptococcus vaccines: progress and potential
Fig. 1. Timeline of GBS discovery to the time it was considered the predominant pathogen causing sepsis and meningitis in neonates. GBS, Group B Streptococcus.
Ann Clin Microbiol 2023;26:41-50. Group B Streptococcus vaccines: progress and potential
Fig. 1. Comparison of perceptions of the sensitivity and specificity of diagnostic tests for Clostridioides difficile infection among physicians and clinical pathologists. EIA, enzyme immunoassay; NAAT, nucleic acid amplification test.
Ann Clin Microbiol 2023;26:75-82. A survey of physicians’ perceptions of diagnostic tests for Clostridioides difficile infection
Fig. 2. Flowchart for implementation aminopenicillin MIC for Enterobacterales. AMC, amoxicillin-clavulanic acid; Tx, therapy; UTI, urinary tract infection; uUTI, uncomplicated UTI; MIC, minimum inhibitory concentration; S, susceptiblie; R, resistant; IV, intravenous; cUTI, complicated UTI; I, intermediate.
Ann Clin Microbiol 2023;26:51-57. Introduction to the revised international guidelines on breakpoints for antimicrobial susceptibility testing
Fig. 1. Cascade reporting examples for Enterobacterales.
Ann Clin Microbiol 2023;26:51-57. Introduction to the revised international guidelines on breakpoints for antimicrobial susceptibility testing
Table 1. The variant types of real-time PCR observed during this study period (2021.01-2022.03)
Ann Clin Microbiol 2023;26:83-86. SARS-CoV2 mutation detection experience using PowerChek SARS-CoV-2 S-gene Mutation Detection Kit Variant Predominance period by variant type No. of samples (%) Pre-delta(2020.1.20–2021.7.24) Delta(2021.7.25-2022.1.15) Omicron BA.1/BA.2(2022.1.16-2022.7.23) SARS-CoV-2 20 1 – 021 (5.3) Alpha 5 – – 005 (1.3) Delta 6 204 11 221 (55.5) Omicron.BA.1 – 1 22 023 (5.8) Omicron.BA.2 […]
Table 1. Comparison of perceptions of diagnostic tests for Clostridioides difficile infection among physicians and clinical patholosits
Ann Clin Microbiol 2023;26:75-82. A survey of physicians’ perceptions of diagnostic tests for Clostridioides difficile infection Physicians Clinical pathologists Perception on the algorithmic test Useful Useful but in need of countermeasures Not useful Sum Useful 0 1 0 1 Useful but in need of countermeasures 8 10 1 19 Not useful 1 0 0 1 […]
Table 3. Detection of the targeted protozoa among 51 non-diarrheal fecal samples obtained from nondiarrheal healthy controls using molecular diagnostics
Ann Clin Microbiol 2023;26:67-73. Multicenter study on the molecular epidemiology of intestinal protozoan parasites in Korea Center (No. of sample) No. (%) of samples with positive to any protozoa by commercial Real-time PCR kits Cryptosporidium parvum Giardia lamblia Entamoeba histolytica Cyclospora cayetanensis Dientamoeba fragilis Blastocystis hominis Microsporidia species Kudoa septempunctata Center 1 (n=13) 0 0 […]
Table 2. Detection of several protozoa among 279 diarrheal fecal samples obtained from six collection centers
Ann Clin Microbiol 2023;26:67-73. Multicenter study on the molecular epidemiology of intestinal protozoan parasites in Korea Center No. (%) of samples with positive to any protozoa by commercial Real-time PCR kits Cryptosporidium parvum Giardia lamblia Entamoeba histolytica Cyclospora cayetanensis Dientamoeba fragilis Blastocystis hominis Microsporidia species Kudoa septempunctata Center 1 0 0 0 0 0 0 […]
Table 1. Clinical characteristics of the diarrheal patients enrolled in this study
Ann Clin Microbiol 2023;26:67-73. Multicenter study on the molecular epidemiology of intestinal protozoan parasites in Korea Collection Centers Center 1 Center 2 Center 3 Center 4 Center 5 Center 6* Subtotal Region Jeonnam Gyeongnam Kangwon Gwangju Metropolitan area Nationwide Total No. of enrolled patients 43 20 23 38 27 128 279 Female/Male (% Male) 22/21 […]